Motus GI Holdings (STU:7M4) Common Stock : €0.00 Mil (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Motus GI Holdings Common Stock?

Motus GI Holdings's quarterly common stock declined from Jun. 2023 (€0.00 Mil) to Sep. 2023 (€0.00 Mil) but then stayed the same from Sep. 2023 (€0.00 Mil) to Dec. 2023 (€0.00 Mil).

Motus GI Holdings Common Stock Historical Data

The historical data trend for Motus GI Holdings's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Motus GI Holdings Common Stock Chart

Motus GI Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Common Stock

Get a 7-Day Free Trial

Motus GI Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Common Stock	Get a 7-Day Free Trial															-	-	-	-	-

Motus GI Holdings Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Motus GI Holdings (STU:7M4) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Motus GI Holdings Inc (STU:7M4) » Definitions » Common Stock

Comparable Companies

Traded in Other Exchanges

MOTS:USA

Address

1301 East Broward Boulevard, 3rd Floor, Fort Lauderdale, FL, USA, 33301

Website

https://www.motusgi.com

Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the "FDA") to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal ("GI") endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.

Motus GI Holdings (STU:7M4) Headlines

No Headlines